|
|
Volumn 347, Issue 6228, 2015, Pages 1296-1297
|
|
MERS surges again, but pandemic jitters ease: The camel virus appears to be less lethal and more prevalent in humans than assumed
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE;
VIRUS RNA;
VIRUS VACCINE;
COST-BENEFIT ANALYSIS;
DISEASE PREVALENCE;
DISEASE TREATMENT;
EPIDEMIOLOGY;
HEALTH RISK;
HOST-PATHOGEN INTERACTION;
PUBLIC HEALTH;
RUMINANT;
VIRAL DISEASE;
BIOSAFETY;
CORONAVIRUS INFECTION;
DROMEDARY;
DRUG EFFICACY;
DRUG MARKETING;
DRUG SAFETY;
EPIDEMIC;
FATALITY;
HUMAN;
INFECTION PREVENTION;
INFECTION RISK;
LOWER RESPIRATORY TRACT INFECTION;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS INFECTION;
NONHUMAN;
PANDEMIC;
PREVALENCE;
PRIORITY JOURNAL;
SAUDI ARABIA;
SHORT SURVEY;
VACCINATION;
VIRAL RESPIRATORY TRACT INFECTION;
VIRUS CARRIER;
WORLD HEALTH ORGANIZATION;
ANIMAL;
CAMEL;
CORONAVIRUS;
CORONAVIRUS INFECTIONS;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
PATHOGENICITY;
TRANSMISSION;
VETERINARY;
ANIMALS;
CAMELS;
CORONAVIRUS;
CORONAVIRUS INFECTIONS;
HUMANS;
PANDEMICS;
PREVALENCE;
SAUDI ARABIA;
VACCINATION;
VIRAL VACCINES;
|
|
EID: 84925340822
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.347.6228.1296 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (0)
|